GB2257908B - Calcitonin analogue for transmucosal administration - Google Patents

Calcitonin analogue for transmucosal administration

Info

Publication number: GB2257908B
Authority: GB; United Kingdom
Prior art keywords: transmucosal administration; calcitonin analogue; calcitonin; analogue; transmucosal
Prior art date: 1991-07-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

GB9214830A

Other languages

English (en)

Other versions

GB2257908A (en

GB9214830D0 (en

Inventor

Moise Azria

Gert Fricker

Jacky Vonderscher

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-15

Filing date

1992-07-13

Publication date

1995-12-20

1991-07-15 Priority claimed from GB919115202A external-priority patent/GB9115202D0/en

1992-01-14 Priority claimed from GB929200748A external-priority patent/GB9200748D0/en

1992-07-13 Application filed by Sandoz AG filed Critical Sandoz AG

1992-08-26 Publication of GB9214830D0 publication Critical patent/GB9214830D0/en

1993-01-27 Publication of GB2257908A publication Critical patent/GB2257908A/en

1995-12-20 Application granted granted Critical

1995-12-20 Publication of GB2257908B publication Critical patent/GB2257908B/en

2012-07-13 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

GB9214830A 1991-07-15 1992-07-13 Calcitonin analogue for transmucosal administration Expired - Fee Related GB2257908B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919115202A GB9115202D0 (en)	1991-07-15	1991-07-15	Improvements relating to organic compounds
GB929200748A GB9200748D0 (en)	1992-01-14	1992-01-14	Improvements relating to organic compounds

Publications (3)

Publication Number	Publication Date
GB9214830D0 GB9214830D0 (en)	1992-08-26
GB2257908A GB2257908A (en)	1993-01-27
GB2257908B true GB2257908B (en)	1995-12-20

Family

ID=26299234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB9214830A Expired - Fee Related GB2257908B (en)	1991-07-15	1992-07-13	Calcitonin analogue for transmucosal administration

Country Status (7)

Country	Link
JP (1)	JPH05194260A (fr)
BE (1)	BE1007752A5 (fr)
CH (1)	CH685600A5 (fr)
DE (1)	DE4222647A1 (fr)
FR (1)	FR2682598B1 (fr)
GB (1)	GB2257908B (fr)
IT (1)	IT1263222B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698672A (en) *	1995-04-04	1997-12-16	Zymogenetics, Inc.	Synthetic calcitonin mimetics
US5698521A (en) *	1995-04-04	1997-12-16	Zymogenetics, Inc.	Native calcitonin mimetics
AU1808897A (en) *	1995-12-13	1997-07-03	Dullatur Limited	A calcitonin preparation
GB9614235D0 (en) *	1996-07-06	1996-09-04	Danbiosyst Uk	Composition for enhanced uptake of polar drugs from mucosal surfaces
US6228836B1 (en)	1997-04-14	2001-05-08	Mitsubishi-Tokyo Pharmaceuticals, Inc.	Permucous preparation
US7030082B2 (en) *	2001-09-07	2006-04-18	Nobex Corporation	Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2127689A (en) *	1982-10-05	1984-04-18	Sandoz Ltd	Calcitonin inhalation compositions
EP0122036A1 (fr) *	1983-03-09	1984-10-17	Teijin Limited	Composition pharmaceutique poudreuse pour application nasale
EP0193372A2 (fr) *	1985-02-25	1986-09-03	Teijin Limited	Composition pharmaceutique sous forme de poudre applicable par voie intranasale
GB2218102A (en) *	1988-04-08	1989-11-08	Sandoz Ltd	Peptide derivatives
EP0432431A1 (fr) *	1989-11-16	1991-06-19	PHIDEA S.p.A.	Composition liquide pharmaceutique pour application nasale contenant un polypeptide comme ingrédient actif

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4151276A (en) *	1975-05-12	1979-04-24	Armour Pharmaceutical Company	Method of suppressing gastric acid secretion by the oral administration of calcitonin
IL70489A0 (en) *	1982-12-29	1984-03-30	Armour Pharma	Pharmaceutical compositions containing calcitonin
HU203204B (en) *	1987-09-15	1991-06-28	Sandoz Ag	Process for producing suppository containing calcitonin and taurocholic acid
HU206367B (en) *	1988-04-30	1992-10-28	Sandoz Ag	Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
JP2911496B2 (ja) *	1989-09-11	1999-06-23	帝國製薬株式会社	生理活性ポリペプチド含有高吸収性経膣剤

1992
- 1992-07-10 DE DE4222647A patent/DE4222647A1/de not_active Withdrawn
- 1992-07-13 BE BE9200650A patent/BE1007752A5/fr not_active IP Right Cessation
- 1992-07-13 FR FR9208675A patent/FR2682598B1/fr not_active Expired - Fee Related
- 1992-07-13 GB GB9214830A patent/GB2257908B/en not_active Expired - Fee Related
- 1992-07-13 CH CH2194/92A patent/CH685600A5/de not_active IP Right Cessation
- 1992-07-14 JP JP4186621A patent/JPH05194260A/ja active Pending
- 1992-07-14 IT ITRM920535A patent/IT1263222B/it active IP Right Grant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2127689A (en) *	1982-10-05	1984-04-18	Sandoz Ltd	Calcitonin inhalation compositions
EP0122036A1 (fr) *	1983-03-09	1984-10-17	Teijin Limited	Composition pharmaceutique poudreuse pour application nasale
EP0193372A2 (fr) *	1985-02-25	1986-09-03	Teijin Limited	Composition pharmaceutique sous forme de poudre applicable par voie intranasale
GB2218102A (en) *	1988-04-08	1989-11-08	Sandoz Ltd	Peptide derivatives
EP0432431A1 (fr) *	1989-11-16	1991-06-19	PHIDEA S.p.A.	Composition liquide pharmaceutique pour application nasale contenant un polypeptide comme ingrédient actif

Also Published As

Publication number	Publication date
GB2257908A (en)	1993-01-27
JPH05194260A (ja)	1993-08-03
DE4222647A1 (de)	1993-01-21
FR2682598A1 (fr)	1993-04-23
ITRM920535A1 (it)	1994-01-14
BE1007752A5 (fr)	1995-10-17
FR2682598B1 (fr)	1996-04-05
IT1263222B (it)	1996-08-05
ITRM920535A0 (it)	1992-07-14
GB9214830D0 (en)	1992-08-26
CH685600A5 (de)	1995-08-31

Publication	Publication Date	Title
ZA924719B (en)	1993-12-27	Pharmaceutical composition
GB9210579D0 (en)	1992-07-01	Pharmaceutical composition
ZA923765B (en)	1993-11-22	Pharmaceutical composition
AP9200382A0 (en)	1992-07-31	Pharmaceutical formulations
ZA921037B (en)	1992-11-25	Pharmaceutical composition
GB9108080D0 (en)	1991-06-05	Pharmaceutical composition
GB9103302D0 (en)	1991-04-03	Pharmaceutical formulations
IL102435A0 (en)	1993-01-14	Pharmaceutical composition
GB2257908B (en)	1995-12-20	Calcitonin analogue for transmucosal administration
IL103226A0 (en)	1993-02-21	Pharmaceutical compositions containing calcitonin
GB2252497B (en)	1995-01-18	Pharmaceutical composition
GB9111477D0 (en)	1991-07-17	Pharmaceutical composition
ZA921848B (en)	1992-11-25	Pharmaceutical composition
GB9113380D0 (en)	1991-08-07	Dosage form
GB9108129D0 (en)	1991-06-05	Pharmaceutical composition
HU9401681D0 (en)	1994-09-28	Pharmaceutical composition
GB9125862D0 (en)	1992-02-05	Pharmaceutical composition
GB9123491D0 (en)	1991-12-18	Pharmaceutical composition
GB9122967D0 (en)	1991-12-18	Pharmaceutical composition
ZA923671B (en)	1993-11-22	Pharmaceutical composition
ZA923077B (en)	1992-11-25	Pharmaceutical composition
ZA921849B (en)	1992-11-25	Pharmaceutical composition
GB9121138D0 (en)	1991-11-13	Pharmaceutical composition
GB9118343D0 (en)	1991-10-09	Pharmaceutical composition
GB9116274D0 (en)	1991-09-11	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
1998-03-04	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 19970713